Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience.

Journal: Scandinavian journal of urology
Published Date:

Abstract

OBJECTIVES: To assess treatment response (PSA < 0.2 ng/ml), need for additional therapy and complication rate after robot assisted salvage pelvic lymph node dissection (sPLND).

Authors

  • Olav Andreas Hopland
    Department of Urology, Radiumhospital, Oslo University Hospital, Oslo, Norway.
  • Sophie D Fosså
    National Advisory Unit on Late Effects after Cancer Treatment, Radiumhospitalet, Oslo University, Oslo, Norway.
  • Fredrik Ottosson
    Department of Urology, Radiumhospital, Oslo University Hospital, Oslo, Norway.
  • Bjørn Brennhovd
    Department of Urology, Radiumhospital, Oslo University Hospital, Oslo, Norway.
  • Aud Svindland
    Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Knut Håkon Hole
    d Department of Radiology and Nuclear Medicine , Oslo University Hospital , Oslo , Norway.
  • Eivor Hernes
    Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Lars Magne Eri
    Department of Urology, Radiumhospital, Oslo University Hospital, Oslo, Norway.
  • Lien My Diep
    Oslo Centre for Biostatistics and Epidemiology (OCBE), Oslo University Hospital, Oslo, Norway.
  • Viktor Berge
    Department of Urology, Radiumhospital, Oslo University Hospital, Oslo, Norway.